These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1891785)

  • 21. Emergence of red blood cell agglutinins following renal transplantation in a patient with systemic lupus erythematosus.
    Stevens J; Callender CO; Jilly PN
    Transplantation; 1981 Nov; 32(5):398-400. PubMed ID: 7036456
    [No Abstract]   [Full Text] [Related]  

  • 22. An anti-B lectin from Zea mays everta.
    Prodanov P; Atanasova N
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(1):84-5. PubMed ID: 6202604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel cis-AB variant allele arising from a nucleotide substitution A796C in the B transferase gene.
    Mifsud NA; Watt JM; Condon JA; Haddad AP; Sparrow RL
    Transfusion; 2000 Oct; 40(10):1276-7. PubMed ID: 11061869
    [No Abstract]   [Full Text] [Related]  

  • 24. Challenging dogma: group A donors as "universal plasma" donors in massive transfusion protocols.
    Isaak EJ; Tchorz KM; Lang N; Kalal L; Slapak C; Khalife G; Smith D; McCarthy MC
    Immunohematology; 2011; 27(2):61-5. PubMed ID: 22356521
    [No Abstract]   [Full Text] [Related]  

  • 25. ABO blood group and susceptibility to urinary tract infection: no evidence for involvement of isohaemagglutinins.
    Blackwell CC; Andrew S; May SJ; Weir DM; MacCallum C; Brettle RP
    J Clin Lab Immunol; 1984 Dec; 15(4):191-4. PubMed ID: 6396412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural anti-A and anti-B of the ABO system: allo- and autoantibodies have different epitope specificity.
    Obukhova P; Korchagina E; Henry S; Bovin N
    Transfusion; 2012 Apr; 52(4):860-9. PubMed ID: 21981750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transplantation of blood group A2 kidneys into O or B recipients: the effect of pretransplant anti-A titers on graft survival.
    Welsh KI; van Dam M; Koffman CG; Bewick ME; Rudge CJ; Taube DH; Clark AG
    Transplant Proc; 1987 Dec; 19(6):4565-7. PubMed ID: 3321621
    [No Abstract]   [Full Text] [Related]  

  • 28. Alternative strategy for overcoming ABO incompatibility.
    Kobayashi T; Liu D; Ogawa H; Miwa Y; Nagasaka T; Maruyama S; Li YT; Onishi A; Kuzuya T; Kadomatsu K; Uchida K; Nakao A
    Transplantation; 2007 May; 83(9):1284-6. PubMed ID: 17496551
    [No Abstract]   [Full Text] [Related]  

  • 29. [Unusual properties of anti-A1 antibodies in case of tumor of neural origin].
    Walewska I; KuĊ›nierz G; Scharf R
    Acta Haematol Pol; 1980; 11(1):41-8. PubMed ID: 7368895
    [No Abstract]   [Full Text] [Related]  

  • 30. Outcome of ABO-incompatible liver transplantation in children with no specific alloantibodies at the time of transplantation.
    Yandza T; Lambert T; Alvarez F; Gauthier F; Jacolot D; Huault G; Fabre M; Valayer J
    Transplantation; 1994 Jul; 58(1):46-50. PubMed ID: 8036707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody to blood group glycosyltransferases in a patient transplanted with an ABO incompatible bone marrow.
    Kominato Y; Fujikura T; Takizawa H; Hayashi K; Mori T; Matsue K; Yasue S; Matsuda T
    Exp Clin Immunogenet; 1990; 7(2):85-90. PubMed ID: 2108709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-A and anti-B: what are they and where do they come from?
    Branch DR
    Transfusion; 2015 Jul; 55 Suppl 2():S74-9. PubMed ID: 26174901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mouse monoclonal anti-A and anti-B as routine blood grouping reagents: an evaluation.
    Munro AC; Inglis G; Blue A; Sheridan R; Mitchell R
    Med Lab Sci; 1982 Apr; 39(2):123-7. PubMed ID: 7121214
    [No Abstract]   [Full Text] [Related]  

  • 34. Development of a C1q-ABO-ELISA to measure C1q binding by human anti-A alloantibodies.
    von Allmen E; Rieben R; Nydegger UE
    J Immunol Methods; 1994 May; 171(1):85-92. PubMed ID: 8176240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions of IgM ABO antibodies and complement with methoxy-PEG-modified human RBCs.
    Bradley AJ; Test ST; Murad KL; Mitsuyoshi J; Scott MD
    Transfusion; 2001 Oct; 41(10):1225-33. PubMed ID: 11606820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antiplatelet antibody].
    Shibata Y; Yamanaka M
    Rinsho Byori; 1985 Jul; 33(7):734-41. PubMed ID: 3934431
    [No Abstract]   [Full Text] [Related]  

  • 37. Establishment of a simple detection system for blood group ABO-specific transferase activity in DNA-transfected cells.
    Nishida C; Nishiyama C; Satoh K; Hara M; Itoh Y; Ogawa H; Okumura K
    Leg Med (Tokyo); 2010 Jul; 12(4):172-6. PubMed ID: 20471900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Isoagglutinins of the ABO system in universal blood preparations (KU-ABO) used for exchange transfusions in hemolytic disease of the newborn].
    Cwik J
    Pediatr Pol; 1985 Sep; 60(9):652-7. PubMed ID: 3831898
    [No Abstract]   [Full Text] [Related]  

  • 39. [Analysis of antigens against anti-platelet antibody detected in patients with EDTA-dependent pseudothrombocytopenia].
    Saigo K; Ryo R; Hashimoto M; Ueda K; Nakaya Y; Hirai K; Yamaguchi N
    Rinsho Ketsueki; 1986 Aug; 27(8):1305-9. PubMed ID: 3099034
    [No Abstract]   [Full Text] [Related]  

  • 40. Monoclonal anti-A and anti-B: development as cost-effective reagents.
    Voak D; Lennox E; Sacks S; Milstein C; Darnborough J
    Med Lab Sci; 1982 Apr; 39(2):109-22. PubMed ID: 6811828
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.